Introduction {#s1}
============

Macrophages represent a highly specialized and versatile population of cells that occur in all animals and perform a diversity of functions ([@bib40]). In the absence of an activating stimulus, macrophages reside as quiescent sentinel cells that have minimal metabolic requirements ([@bib12]). In response to extracellular triggers, however, macrophages undergo a dramatic change in behavior that coincides with an enhanced metabolic rate and increased energy demands ([@bib52]). In this regard, the manner by which macrophages mount a response is dictated by the activating stimuli, which include tissue-damage-, pathogen- or microbe-associated molecular patterns (DAMPs, PAMPs and MAMPs, respectively), as well as signaling molecules that are secreted by other cells, such as cytokines. Each challenge requires the induction of specific metabolic and physiological processes that allow for an adequate immune response ([@bib31]) -- cellular changes that are collectively known as a polarization phenotype.

Macrophages polarize into bactericidal (M1) or healing (M2) functional phenotypes characterized mainly by metabolism ([@bib43]). M1 and M2 polarization phenotypes utilize distinct ways of generating ATP (glycolysis vs. oxidative phosphorylation) and metabolizing arginine (NO synthesis vs. the ornithine cycle) ([@bib50]). Nowadays, the whole spectrum of polarization phenotypes corresponding to particular functions has been described ([@bib46]; [@bib42]). Perhaps the most dramatic change in macrophage metabolism associates with the M1 bactericidal phenotype, in which cells increase both glucose consumption and lactate production independently of oxygen concentration - a phenomenon known as aerobic glycolysis (AG) ([@bib62]; [@bib63]). The resulting metabolic program promotes increased glucose catabolism, thus allowing M1 macrophages to generate enough of the ATP and glycolytic intermediates necessary for elevated phagocytic cell activity ([@bib39]). This shift in cellular metabolism towards AG appears to be a determining factor in macrophage function and in the development of the pro-inflammatory phenotype ([@bib19]).

Hypoxia inducible factor 1α (HIF1α) is a key regulator of AG within macrophages. Although this transcription factor is normally degraded in the presence of oxygen, the triggering of either Toll-like receptor (TLR) or Tumor necrosis factor receptor (TNFR) signaling within macrophages activates Nuclear factor kappa-B (NFĸB) and stabilizes HIF1α independently of oxygen availability ([@bib57]; [@bib29]). This normoxic HIF1α stabilization promotes the expression of genes that are under the control of hypoxia response elements (HREs), many of which are involved in cellular metabolism, cell survival, proliferation, and cytokine signaling ([@bib13]). In this regard, two of the key HIF1α target genes encode the enzymes pyruvate dehydrogenase kinase (PDK) and lactate dehydrogenase (LDH), which together shunt pyruvate away from the mitochondria and maintain NAD^+^/NADH redox balance independently of oxidative phosphorylation. Inhibition of both HIF1α and LDH represents an efficient experimental strategy to direct cellular metabolism from AG to oxidative phosphorylation in both mice and *Drosophila* ([@bib1]; [@bib20]), demonstrating the crucial role of these enzymes in this metabolic switch.

Although pyruvate metabolism within the tricarboxylic acid (TCA) cycle is limited during AG, the TCA intermediates are essential for many cellular processes. Therefore, cells under AG rely on feeding the TCA cycle with glutamine, causing a TCA cycle to be 'broken' ([@bib35]). Such a dramatic change in mitochondrial metabolism leads to significant imbalances in the cytosolic accumulation of TCA metabolites (such as NO, succinate, fumarate, L-2-hydroxyglutarate) that further contribute to HIF1α stabilization ([@bib5]). While this feedback maintains AG, it simultaneously makes it dependent on a sufficient supply of nutrients from the environment ([@bib25]).

Macrophages employing AG must consume sufficient carbohydrates to support biosynthesis and growth. In order to ensure an adequate supply of sugar and other nutrients, these cells produce signaling molecules that affect systemic metabolism in order to secure enough energy for themselves -- a concept recently defined as selfish immune theory ([@bib27]; [@bib58]). According to this theory, signaling molecules released by immune cells induce systemic metabolic changes such as hyperglycemia and systemic insulin resistance to increase the titer of nutrients that are available for the immune response and to limit their consumption by other tissues and processes ([@bib14]). As many of these signaling molecules are direct HIF1α transcriptional targets, HIF1α stabilization directs the cellular metabolism while it simultaneously induces the expression of genes that have an impact on the whole systemic metabolism ([@bib53]; [@bib24]). Thus, macrophages not only phagocytose cells but they also regulate the systemic metabolism of an organism.

*Drosophila* macrophages, like those of mammals, serve an essential role in the immune system and are capable of responding to a wide array of stimuli, ranging from pathogenic bacteria and fungi to the corpses of apoptotic cells ([@bib66]; [@bib56]; [@bib22]). The mechanism of the bactericidal function itself is highly conserved at the molecular level between *Drosophila* and mammalian macrophages. In both *Drosophila* and mammals, two central signaling pathways, Toll and Imd (TLR and TNFR functional homologs) are triggered in response to pathogenic stimuli ([@bib59]; [@bib9]; [@bib37]). The Toll and Imd pathways induce the NFĸB signaling in *Drosophila*, so we can assume that the phagocytic role of macrophages could be accompanied by stabilization of the HIF1α ortholog, *Similar* (*Sima*), hereafter referred to as Hif1α ([@bib60]). Indeed, normoxic stabilization of Hif1α followed by its nuclear localization and increased expression of HRE-controlled genes can induce metabolic changes that are typical of AG ([@bib55]; [@bib38]; [@bib41]; [@bib23]; [@bib15]). Even though the HRE-controlled genes frequently appear in transcriptomic data for activated insect macrophages ([@bib26]; [@bib28]), the direct role of Hif1α in the macrophages has not yet been tested.

Considering that the molecular mechanisms that control macrophage activation are similar in both *Drosophila* and humans, it seems logical that the metabolic changes that occur within these cells would also be comparable, but the metabolism of insect macrophages remains poorly understood. Here, we address this question by analyzing in vivo metabolic and transcriptional changes in adult *Drosophila* phagocytic macrophages by employing a model of *Streptococcus-pneumoniae-*induced sepsis. The well-defined progress of this infection allowed us to distinguish three phases of the immune response according to the changing dynamics of bacterial growth (acute, plateau, and resolution phase) ([Figure 1A](#fig1){ref-type="fig"}). The acute phase lasts for the first 24 hr, during which the streptococcal population is rapidly growing and its abundance must be limited by phagocytosis to avert early death ([@bib54]; [@bib7]). The established equilibrium between continuous bacterial growth and host bacterial killing results in the plateau phase lasting for the next four days. At the end of this period, the immune system of the host surmounts the infection and clears the majority of the pathogens. The following resolution phase (120 hr post-infection (hpi) and later) is essential for macrophage-mediated clearance of bacterial residues and for the reestablishment of homeostasis ([@bib7]; [@bib10]).

![Graphical representation of the experimental approach.\
(**A**) The natural progress of streptococcal infection, with highlighted sampling times during the acute and resolution phases of infection. The Y axis indicates the percentage of surviving adults. (**B**) The approach used to isolate hemocytes, which are subsequently assayed for gene expression and enzymatic activities. Macrophages sorted from flies at the respective time points post-infection represent acute-phase macrophages (APMФs; 24 hpi) and resolution-phase macrophages (RPMФs; 120 hpi). Control flies were analyzed at the same time points after receiving injection of phosphate-buffered saline (PBS). hpi, hours post-infection; FACS, fluorescence-activated cell sorting; S.p., *Streptococcus pneumoniae*.](elife-50414-fig1){#fig1}

To analyze processes that are characteristic of highly active phagocytic macrophages in *Drosophila*, we compared the attributes of acute phase macrophages (APMФs) with those of macrophages from uninfected individuals and resolution-phase macrophages (RPMФs). Using a previously described hemolectin-driven GFP (*HmlGal4 \>UAS* eGFP) ([@bib30]), we isolated *Drosophila* adult macrophages (approximately 15,000 cells/replicate) and analyzed the metabolic and transcriptional responses that are induced within these cells upon infection ([Figure 1B](#fig1){ref-type="fig"}). Our approach revealed that *Drosophila* macrophages respond to the acute phase of bacterial infection by increasing glucose uptake, elevating glycolytic flux, and producing lactate. Moreover, as in mammals, the activation and maintenance of AG within *Drosophila* macrophages depend on Hif1α, and require elevated Ldh activity. We also demonstrate that the induction of AG within *Drosophila* macrophages leads to a change in systemic carbohydrate metabolism. Overall, our findings demonstrate that *Drosophila* macrophages must induce both autonomous and systemic changes in carbohydrate metabolism to mount a proper bactericidal function and to resist infection.

Results {#s2}
=======

*Drosophila* macrophages undergo a metabolic shift to aerobic glycolysis during the acute phase of bacterial infection {#s2-1}
----------------------------------------------------------------------------------------------------------------------

Since the bactericidal function of phagocytic cells is connected with AG in mice ([@bib43]), we analyzed *Drosophila* macrophages for the occurrence of AG hallmarks, such as increased glucose uptake, an increase in glycolytic flux, and the generation of an NADH pool facilitating the Ldh-mediated reduction of pyruvate to lactate ([@bib35]). The distribution of fluorescently labeled deoxyglucose (NBDG) in an organism, frequently used in cancer research, reflects the competitive potential of tissues in glucose internalization ([@bib11]). We tested the effect of immune response activation on glucose distribution among tissues in *Drosophila* by feeding the infected or control flies with NBDG during a 24-hr period before the signal detection. Infected flies displayed prominent NBDG accumulation in APMФs compared to other tissues, which is in contrast to the distribution of NBDG seen in uninfected controls or in flies fed during the resolution phase of infection, which displayed no such accumulation ([Figure 2A,B](#fig2){ref-type="fig"}). These results indicate an increased potential of phagocytosing macrophages to consume glucose in direct competition with other tissues during the acute phase of bacterial infection.

![Streptococcal infection enhances glycolysis in acute-phase macrophages.\
(**A--B**) Fluorescent images of the dorsal view of the abdomens of infected and control (both Hml \>GFP) flies at 24 and 120 hpi, showing NBDG the distribution among the tissues (**A**) and at a higher magnification (**B**). Images represent a minimum of ten observations of a similar pattern. (**C**) Scheme of glycolysis and the TCA cycle, highlighting significant changes in the quantified expression of the indicated genes at 24 and 120 hpi. The expression levels of the mRNA were measured relative to that of the ribosomal protein 49 (rp49), and the statistical significance (p\<0.05) was tested using ANOVA (for data see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Upregulated genes are shown in red, downregulated genes in green; gray indicates no statistically significant difference. (**D--F**) Enzymatic activities of phosphoglucose isomerase (Pgi) (**D**) and lactate dehydrogenase (Ldh) (**E**), as well as the level of NADH (**F**), at 24 and 120 hpi measured in the homogenate of hemocytes isolated from infected and control flies. The levels of enzymatic activity and NADH concentration were normalized per ten thousand cells per sample. (**G**) The concentration of circulating lactate measured in the hemolymph of infected and control flies at 24 and 120 hpi. In all plots (**D--G**), individual dots represent biological replicates. Values are mean ± SD, asterisks mark statistically significant differences (\*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001).\
10.7554/eLife.50414.007Figure 2---source data 1.Metabolic characterization of macrophages post-infection.](elife-50414-fig2){#fig2}

The increased NBDG uptake by macrophages was further supported by gene expression analysis, which revealed that the transcription of genes encoding both glycolytic enzymes and LDH, but not TCA cycle enzymes, was significantly upregulated in APMФs ([Figure 2C](#fig2){ref-type="fig"}). Moreover, these changes in glycolytic genes were restricted to the acute phase of infection as most glycolytic genes returned to a basal level of expression during the resolution phase, whereas hexokinase and enolase (similarly to all analyzed TCA cycle genes) even showed decreased expression ([Figure 2C](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), which can be ascribed to the global suppression of metabolism in these cells. Overall, these results indicate that macrophages specifically upregulate glucose metabolism in response to *S. pneumoniae* infection.

Increased glucose uptake and expression of glycolytic genes, including *Ldh*, suggest an increased glycolytic flux and preferential reduction of pyruvate to lactate in APMФs. To confirm this, we measured the enzymatic activity of LDH, as an enzyme responsible for the diversion of pyruvate from TCA, and phosphoglucose isomerase (Pgi), as a glycolytic enzyme representative. In agreement with the expression data, Pgi enzymatic activity was significantly increased in APMФs compared to control and compared to the situation observed during the resolution phase of infection ([Figure 2D](#fig2){ref-type="fig"}). The activity of Ldh increased not only in APMФs but also in RPMФs ([Figure 2E](#fig2){ref-type="fig"}). Moreover, the observed increase in Ldh activity was directly correlated with increased lactate production in vivo, as the hemolymph of infected individuals during both the acute and the resolution phases of infection contained significantly elevated lactate levels as compared to controls ([Figure 2G](#fig2){ref-type="fig"}). Overall, our results demonstrate that *Drosophila* macrophages respond to *S. pneumoniae* infection by upregulating lactate production.

The primary reason why cells produce lactate as a byproduct of AG is to maintain NAD^+^/NADH redox balance. High levels of glycolytic flux produce excess NADH as a result of glyceraldehyde-3-phosphate dehydrogenase 1 (Gapdh1) activity ([@bib51]). Consistently, we observed that NADH levels were significantly increased in APMФs and, to a lesser extent, in RPMФs when compared with controls ([Figure 2F](#fig2){ref-type="fig"}). When considered in the context of gene expression and enzyme activity assays, these results support a model in which activated *Drosophila* macrophages undergo a dramatic metabolic remodeling towards AG during bacterial infection.

Hif1α and Ldh activities are increased in *Drosophila* macrophages during the acute phase of infection {#s2-2}
------------------------------------------------------------------------------------------------------

Since Hif1α can induce AG in both murine and *Drosophila* cells ([@bib53]; [@bib23]; [@bib15]), we examined the possibility that this transcription factor also promotes glucose catabolism within activated macrophages. Although Hif1α is known to be expressed continuously in almost all tissues and regulated predominantly at the post-translational level, we observed that *Hif1α* mRNA was significantly elevated in APMФs ([Figure 3D](#fig3){ref-type="fig"}). To determine whether this increase correlates with the elevated expression of Hif1α target genes, we used a transgenic β-galactosidase reporter under the control of a HRE (*HRE-LacZ*), which is primarily induced by HIF1α ([@bib36]) although the involvement of other transcription factors cannot be entirely excluded. Although some cells exhibited *HRE-LacZ* expression in uninfected individuals, the number of β-galactosidase-positive macrophages rose dramatically in flies during the acute phase of infection ([Figure 3A](#fig3){ref-type="fig"}). These results suggest that Hif1α activity is increased in APMФs and confirms the previously reported expression pattern of glycolytic genes (see [Figure 2---figure supplement 1A--F](#fig2s1){ref-type="fig"}).

![Macrophage-specific activities of Hif1α and Ldh increase upon infection.\
(**A**) X-gal staining of infected and control flies bearing the HRE-LacZ reporter construct. Images represent a minimum of ten observations of a similar pattern. (**B**) An uninfected Hml \>GFP, Ldh-mCherry adult fly (24 hpi) shows localization of the Ldh reporter activity (red) in many of the immune cells (green). The image is a Z-stack at maximal projection of 25 confocal slices. (**C, D**) Expression of Ldh (**C**) and Hif1α (**D**) mRNAs in hemocytes isolated from infected and control flies (both Hml \>GFP; 24 and 120 hpi). (**E**) Expression of Ldh mRNA in hemocytes of infected and control Hml \>GFP flies with and without a hemocyte-specific knockdown of Hif1α at 24 hpi. In all plots (**C--E**), expression levels, normalized against rp49, are given as fold change (F.C.) relative to levels in PBS-injected Hml \>GFP controls (24 hpi), which were arbitrarily set to 1. Individual dots represent biological replicates. Values are mean ± SD, asterisks mark statistically significant differences (\*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001).\
10.7554/eLife.50414.009Figure 3---source data 1.Expression pattern of Hif1α and Ldh genes.](elife-50414-fig3){#fig3}

As increased lactate production is a hallmark of AG, we examined *Ldh* expression in macrophages using a transgene that expresses a Ldh-mCherry fusion protein from an endogenous *Ldh* promoter. The expression of Ldh-mCherry in adult flies harboring the *HmlGal4 \>UAS* eGFP reporter revealed that macrophages from uninfected adults expressed *Ldh* at levels that markedly exceeded the expression of this reporter in other tissues. This perhaps indicates that these cells are primed to generate lactate prior to infection ([Figure 3B](#fig3){ref-type="fig"}), as the Ldh-mCherry pattern did not change significantly after infection (data not shown). *Ldh* expression, however, was significantly upregulated in APMФs ([Figure 3C](#fig3){ref-type="fig"}), further supporting our observation that *S. pneumoniae* induces Ldh activity ([Figure 2E](#fig2){ref-type="fig"}), which is in agreement with elevated NADH levels ([Figure 2G](#fig2){ref-type="fig"}). The regulation of *Ldh* expression by Hif1α in activated immune cells was verified by knocking down *Hif1α* expression in macrophages 24 hr before infection (*Hml \>Hif1α\[RNAi\]*). This strategy not only reduced *Hif1α* expression within APMФs ([Figure 4---figure supplement 1G](#fig4s1){ref-type="fig"}), but also led to the loss of the ability to increase *Ldh* expression in APMФs, indicating that Hif1α is essential for the elevated Ldh activity in APMФs ([Figure 3E](#fig3){ref-type="fig"}).

Hif1α promotes aerobic glycolysis in *Drosophila* macrophages during bacterial infection {#s2-3}
----------------------------------------------------------------------------------------

To determine whether the observed increase in Hif1α activity is necessary to trigger AG in stimulated macrophages, we used *Hml \>Hif1α\[RNAi\]* and examined the metabolic consequences. This treatment led to the abrogation of the metabolic changes associated with AG. Following infection, APMФs expressing *Hif1α\[RNAi\]* did not accumulate NBDG ([Figure 4A](#fig4){ref-type="fig"}), and failed to show increased expression of glycolytic genes (with the exception of Gpdh1) ([Figure 4B](#fig4){ref-type="fig"}). Moreover, these *Hml \>Hif1α\[RNAi\]-*expressing cells exhibited no increase in either Pgi or Ldh enzyme activity and displayed decreased NADH levels when compared with controls ([Figure 4D,E,F](#fig4){ref-type="fig"}). These results indicate that Hif1α activity is essential for inducing AG in macrophages during the immune response.

![Effects of Hif1α and Ldh hemocyte-specific knockdown on macrophage metabolism.\
(**A**) Dorsal view of the abdomens of S.p.-infected flies (24 hpi) showing the distribution of the fluorescent NBDG probe. Controls (left) are compared to flies subjected to hemocyte-specific knockdown of Hif1α. Images represent a minimum of ten observations of a similar pattern. (**B**) Schematic representation of the expression of genes encoding metabolic enzymes in the hemocytes of infected control flies (left) and of flies with Hif1α hemocyte-specific knockdown (right) at 24 hpi. The expression levels of the mRNAs were measured relative to that of rp49, and the statistical significance (p\<0.05) was tested using ANOVA (for data see [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Upregulated genes are shown in red; gray indicates no statistically significant difference. (**C**) Dorsal view of the abdomens of S.p.-infected flies (24 hpi) showing the distribution of the fluorescent NBDG probe. Controls (left) are compared to flies subjected to hemocyte-specific knockdown of Ldh. Images represent a minimum of ten observations of a similar pattern. (**D--F**) Enzymatic activity of Ldh (**D**), level of NADH (**E**), and enzymatic activity of Pgi (**F**) at 24 and 120 hpi measured in lysates of hemocytes isolated from infected and non-infected control flies and from flies with Hif1α hemocyte-specific knockdown. (**G--I**) Enzymatic activity of Ldh (**G**), level of NADH (**H**), and enzymatic activity of Pgi (**I**) at 24 and 120 hpi measured in lysates of hemocytes isolated from infected and non-infected control flies and from flies with Ldh hemocyte-specific knockdown. In all plots (**D--I**), the enzyme activities and NADH concentrations were normalized per ten thousand cells per sample. Individual dots represent biological replicates. Values are mean ± SD, asterisks mark statistically significant differences (\*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001).\
10.7554/eLife.50414.013Figure 4---source data 1.Effect of macrophage-specific Hif1α knockdown on metabolic features of macrophages.](elife-50414-fig4){#fig4}

As a complement to these cell-specific studies of *Hif1α*, we also used *Hml-Gal4* driving *UAS-Ldh\[RNAi\] (Hml \> Ldh\[RNAi\]*) to reduce *Ldh* expression within APMФs. Intriguingly, although this approach successfully reduced Ldh activity in macrophages ([Figure 4G](#fig4){ref-type="fig"}), the metabolic consequences were relatively mild. Within APMФs, *Hml \> Ldh\[RNAi\]* did not disrupt NBDG uptake and Pgi activity remained elevated ([Figure 4C and I](#fig4){ref-type="fig"}). Twenty-four hours after infection, however, we observed that NADH in *Hml \> Ldh\[RNAi\]* macrophages failed to increase to the levels observed in infected controls ([Figure 4H](#fig4){ref-type="fig"}), thus revealing that increased Ldh activity is required for full metabolic reprograming of *Drosophila* macrophages in response to bacterial infection.

Hif1α-mediated aerobic glycolysis in APMфs causes systemic metabolic changes {#s2-4}
----------------------------------------------------------------------------

As we have shown previously ([@bib7]), the systemic metabolic adaptation of carbohydrate metabolism is intimately linked to the effective function of the immune system during streptococcal infection. Therefore, we focused on the characterization of systemic carbohydrate metabolism during the acute phase of infection in *Hml \>Hif1α\[RNAi\]* and *Hml \>Ldh\[RNAi\]* flies ([Figure 5](#fig5){ref-type="fig"}). Both control genotypes underwent the expected metabolic response during the acute phase of streptococcal infection: a significantly raised level of circulating glucose was accompanied by a strong depletion of glycogen stores in tissues. The *Hif1α* silencing completely suppressed the infection-induced changes in carbohydrate metabolism, but infected *Hml \>Ldh\[RNAi\]* flies still significantly increased circulating glucose, albeit to a lesser extent than in the infected controls ([Figure 5A](#fig5){ref-type="fig"}). Although the glycogen stores appeared to be lowered in *Hml \>Ldh\[RNAi\]* flies upon infection, the decrease was statistically insignificant ([Figure 5B](#fig5){ref-type="fig"}). Importantly, the macrophage-specific knockdown of either *Hif1α* or *Ldh* suppressed the occurrence of an infection-induced increase in circulating lactate titer ([Figure 5C](#fig5){ref-type="fig"}). These results show that APMФs are prominent lactate producers during the acute phase of the infection, and suggest that only full activation of APMФs with Hif1α-induced metabolic changes leads to reprograming of systemic carbohydrate metabolism.

![Systemic effects of Hif1α and Ldh hemocyte-specific knockdown.\
(**A--C**) The concentration of circulating glucose (**A**), glycogen stores (**B**) and circulating lactate (**C**) in infected and non-infected flies with Hif1α or Ldh hemocyte-specific knockdown and their respective controls at 24 hpi. The concentrations of metabolites were normalized to the amount of proteins in each sample. Individual dots in the plot represent biological replicates. Values are mean ± SD, asterisks mark statistically significant differences (\*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001).\
10.7554/eLife.50414.015Figure 5---source data 1.Effect of macrophage-specific Hif1α and Ldh knockdown on systemic carbohydrate metabolism.](elife-50414-fig5){#fig5}

Hif1α- and Ldh-mediated metabolic remodeling of APMФs is essential for mounting a successful immune response {#s2-5}
------------------------------------------------------------------------------------------------------------

Our results suggest that *Drosophila* macrophages activate AG and systemic metabolic changes in order to mount a successful immune response. In support of this hypothesis, we observed a significant decrease in the viability of adult flies expressing either *Hml \>Hif1α\[RNAi\]* or *Hml \>Ldh\[RNAi\]* following *S. pneumoniae* infection. By 72 hr post infection, 25% of *Hml \>Hif1α\[RNAi\]* flies died compared to 7% of controls, and the medium time to death (MTD) in *Hml \>Hif1α\[RNAi\]* flies was 10 days compared to 23 days in controls ([Figure 6A](#fig6){ref-type="fig"}). Moreover, pathogen load in *Hml \>Hif1α\[RNAi\]* flies was substantially elevated when compared with that in controls at the second and third day post-infection ([Figure 6C](#fig6){ref-type="fig"}). We observed similar effects in *Hml \>Ldh\[RNAi\]* flies, in which *S. pneumoniae* infection resulted in a decreased survival rate, a MTD of 9 days relative to the 18 days observed in controls, and elevated bacterial load during days 2 and 3 post-infection ([Figure 6B and D](#fig6){ref-type="fig"}). These results reveal that Hif1α and Ldh serve essential roles in both survival of infection and bacterial killing, and demonstrate how shift towards AG associated with systemic metabolic changes in activated macrophages is required to mount a successful immune response.

![Effects of Hif1α and Ldh hemocyte-specific knockdown on resistance to infection.\
(**A--B**) The survival rate of infected flies of the control genotype and of flies with hemocyte-specific Hif1α (**A**) and Ldh (**B**) knockdown. Vertical dotted lines denote medium time to death for each genotype; survival rate during the first 120 hr is shown in detail. Three independent experiments were performed and combined into one survival curve. The average number of individuals per replicate was more than 500 for each genotype. (**C, D**) Colony forming units (CFUs) obtained from infected flies of control genotype and from flies with hemocyte-specific Hif1α (**C**) and Ldh (**D**) knockdown at 0, 24, 48, and 72 hpi. Individual dots in the plot represent the number of bacteria raised from one individual. The data show results merged from three independent biological replicates.\
10.7554/eLife.50414.017Figure 6---source data 1.Effect of macrophage-specific Hif1α and Ldh knockdown on the resistance to bacterial infection.](elife-50414-fig6){#fig6}

Discussion {#s3}
==========

Mammalian macrophages stimulated by bacteria have been shown to rewire their metabolism temporarily towards AG in order to develop an adequate bactericidal response ([@bib51]; [@bib49]; [@bib8]). Although well established in mammals, such metabolic adaptation has not been experimentally tested in insect macrophages to date. We show here that *Drosophila* macrophages that are activated by bacterial infection undergo a dramatic remodeling of cellular metabolism. We demonstrate that acute-phase macrophages exhibit hallmarks of AG, such as elevated uptake of glucose, increased expression and activity of glycolytic genes, elevation of NADH levels, and preferential LDH-mediated conversion of pyruvate to lactate. Through macrophage-specific gene knockdown, we identified Hif1α to be essential for the induction of increased glycolytic flux as well as for the increased activity of LDH. Both Hif1α and Ldh are necessary for the full development of infection-induced changes in systemic carbohydrate metabolism and for resistance to bacterial infection.

A major takeaway of our work is that the cellular response to bacterial infection is an energetically challenging process that imposes significant metabolic demands upon the host. Our findings demonstrate that *Drosophila* macrophages meet these metabolic demands by inducing AG during the acute phase of *S. pneumoniae* infection, as evidenced by the increased expression of glycolytic enzyme genes and elevated NADH levels. This increase in LDH enzyme activity in the absence of elevated TCA cycle activity suggests that macrophages preferentially convert pyruvate to lactate and is consistent with the elevated concentration of lactate observed in hemolymph. However, we find that this metabolic adaptation is temporary, as AG is terminated during the resolution phase of infection. This latter observation is important because it reveals that macrophages temporally regulate metabolic flux throughout an infection and because it establishes *Drosophila* as a powerful model for exploring the molecular mechanisms that control immune cell metabolism.

Our findings also extend the similarities between fly and mammalian models of macrophage polarization, as we identified Hif1α and Ldh as being crucial for the establishment and maintenance of AG in acute-phase macrophages. The importance of these factors is demonstrated by the macrophage-specific *Hif1α* knockdown experiment described above, in which many of the hallmark characteristics of AG, including expression of the *Ldh* gene, were abolished. This finding highlights the conserved and ancient role for Hif1α in regulating the switch between glycolytic and oxidative metabolism ([@bib64]), and suggests that this function evolved as a means of allowing cells to adapt quickly to changing physiological conditions and cell-specific metabolic needs. The role of Hif1α in regulating this switch is of significant interest because, although this transcription factor is classically associated with the response to hypoxia, our study adds to the growing list of examples in which Hif1α remodels cellular metabolism in the context of cell proliferation, activation, and competition, even under normoxic conditions ([@bib45]). Moreover, our finding is particularly intriguing in light of the fact that Hif1α also serves a key role in promoting AG in neoplastic tumor cells ([@bib23]; [@bib15]; [@bib61]). Therefore, our studies of fly macrophages provide a new in vivo system in which we can study how Hif1α promotes cell activity by modulating central carbon metabolism.

While Hif1α drives AG in *Drosophila* macrophages via transcriptional regulation of target genes, the role of Ldh in these cells is more complicated. Although acute-phase macrophages still consume more glucose upon *Ldh* knockdown, these cells exhibit significantly lower Pgi activity and NADH levels, and the titer of circulating lactate also drops. Our results suggest that even though Ldh acts only at the last step of AG, its role is essential for full metabolic reprograming and efficient function of immune cells. *Drosophila* Ldh, like its mammalian ortholog, is responsible for the reduction of pyruvate to lactate, which is linked with the regeneration of NAD^+^ from NADH. However, this single reaction has an immense impact on cellular metabolism. Both the accumulation of pyruvate and the lack of NAD^+^ can become limiting in cells with high glycolytic flux ([@bib51]). In addition, Ldh-dependent removal of cytosolic pyruvate was recently found to be essential to prevent pyruvate entry into mitochondria and a subsequent change of TCA cycle course ([@bib15]; [@bib61]).

Although not addressed in our study, changes in mitochondrial metabolism are also closely associated with AG and should be the focus of future studies of activated *Drosophila* macrophages. The interconnection between the transcriptional activity of Hif1α and the change of mitochondrial metabolism in *Drosophila* has recently been elucidated. The activation of several direct targets of Hif1α transcriptional activity leads to an inhibition of the classical course of the TCA cycle ([@bib61]; [@bib15]). One of the well-understood mechanisms is the prevention of pyruvate entry into the TCA cycle, which is caused by increased kinase activity of pyruvate dehydrogenase kinase 1 (PDK1). PDK1-mediated phosphorylation of pyruvate dehydrogenase (PDH) directly inhibits its enzymatic function, which is essential for pyruvate conversion to acetyl-CoA ([@bib61]). This event causes a cytoplasmic accumulation of TCA cycle intermediates and thus promotes a secondary wave of Hif1α stabilization through inhibition of prolyl hydroxylase dehydrogenase (PHD) under normoxic conditions ([@bib33]; [@bib18]). The change in the TCA cycle is further needed for mitochondrial production of ROS that are transferred to the phagolysosome for bacterial killing ([@bib17]; [@bib65]).

We further demonstrate that both Hif1α and Ldh are crucial not only for full macrophage activation, but also for the bactericidal function of the immune cells, with the rearrangement of macrophage metabolism towards AG being essential for resistance to infection and host survival. An important aspect of AG is the functional dependence of macrophages on sufficient supply of external energy resources, as demonstrated in both mammalian and insect phagocytes ([@bib7]; [@bib2]; [@bib3]; [@bib35]; [@bib48]) and documented here by increased consumption of glucose. Immune cells therefore generate systemic factors to secure sufficient supply of nutrients by altering the function of other organs and by regulating systemic metabolism ([@bib6]; [@bib7]). While the identification of specific signaling factors is beyond the scope of this work, there are several candidate molecules in *Drosophila* that are known to be produced by activated macrophages as a reaction to the metabolic state of the cell. Although it is likely that multiple factors will be involved in this process, we can presume that these factors will reflect the metabolic state of the cells (e.g., extracellular adenosine), or that they will be linked to the transcriptional program that causes the switch towards AG (e.g., Imaginal morphogenesis protein late 2 (ImpL2)). In our previous work, we showed that the systemic metabolic switch upon infection depends on extracellular adenosine, which is produced by the activated immune cells ([@bib7]; [@bib6]). The production of adenosine directly reflects a metabolic state of the cell, such as increased consumption of ATP ([@bib67]), as well as the accelerated occurrence of methylation events ([@bib21]; [@bib68]). Expression of ImpL2 was shown to be regulated by Hif1α ([@bib38]), and as ImpL2 was previously identified as a mediator of cancer-induced loss of energy reserves in flies due to its anti-insulin role ([@bib34]; [@bib16]), it could represent another link between AG in macrophages and changes in systemic metabolism that ensure sufficient supply of energy resources.

Finally, our findings raise an interesting question regarding the links between AG and the ability of immune cells to respond quickly to infection. Recent studies of mammalian macrophage metabolism revealed that AG is essential for the development of innate immune memory - called trained immunity ([@bib47]). The mechanism of trained immunity relies on chromatin remodeling by epigenetic factors that enable cells to react with higher efficiency in response to re-infection by a particular pathogen ([@bib32]). As many chromatin remodeling enzymes need cofactors (such as acetyl-CoA, NAD^+^, α-KG) for the remodeling of the epigenetic landscape, their function can be influenced by the metabolic state of the cell. Induction of AG leads to the accumulation of many cofactors that are essential for a proper function of these enzymes ([@bib32]; [@bib4]). The concept of trained immunity not only is valid for mammals, but is rather present in many invertebrate clades (where it is called immune priming; [@bib44]; [@bib54]). Our observation of AG as a characteristic feature of activated *Drosophila* macrophages thus raises a question of its importance for the development of trained immunity in insects and other invertebrates. Taken together, our findings demonstrate how the molecular mechanisms that control AG induction in *Drosophila* macrophages exhibit a surprisingly high level of evolutionary conservation between mammals and insects, thus emphasizing that this metabolic switch is essential for survival of infection and hinting at the potential role for AG in the development of immune memory.

In conclusion, we have shown that infection-induced systemic changes in carbohydrate metabolism are associated with changes of macrophage cellular metabolism, and that both can be affected by macrophage-specific *Hif1α* and *Ldh* knockdown. Our data thus link the metabolic state of macrophages with the systemic metabolic changes. On the basis of our previous research on the selfish nature of the immune system under challenge ([@bib58]), we envision that the shift in the cellular metabolism of macrophages leads to the production of signals that alter the systemic metabolism, thereby securing the sufficient energy supply necessary to allow the macrophages to fight the infection. By linking the induction of macrophage polarization with systemic metabolism and systemic outcomes in vivo, our experimental system can aid future research towards better understanding of the immune system and of diseases related to its malfunction.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                            Designation                                                             Source\                                         Identifier                                   Additional\
  (species) or\                                                                                                                    reference                                                                                    information
  resource                                                                                                                                                                                                                      
  -------------------------------------------------------- ----------------------------------------------------------------------- ----------------------------------------------- -------------------------------------------- ---------------------------------------------------------------
  Strain, strain background (*Streptococcus pneumoniae*)   *EJ1* strain                                                            Provided by David Schneider                                                                  Dilution 20,000 units

  Chemical compound, drug                                  TRIzol Reagent                                                          Invitrogen                                      Cat\# 15-596-018                             

  Chemical compound, drug                                  Superscript III Reverse Transcriptase                                   Invitrogen                                      Cat\# 18080044                               

  Chemical compound, drug                                  2x SYBR Master Mix                                                      Top-Bio                                         Cat\# T607                                   

  Chemical compound, drug                                  2-NBDG                                                                  Thermo Fisher\                                  Cat\# N13195                                 
                                                                                                                                   Scientific                                                                                   

  Chemical compound, drug                                  X-gal                                                                   Sigma                                           Cat\# B4252                                  

  Commercial assay, kit                                    Glucose (GO) Assay Kit                                                  Sigma                                           Cat\# GAGO20-1KT                             

  Commercial assay, kit                                    Bicinchoninic Acid Assay Kit                                            Sigma                                           Cat\# BCA1                                   

  Commercial assay, kit                                    Lactate Assay Kit                                                       Sigma                                           Cat\# MAK064                                 

  Commercial assay, kit                                    Lactate Dehydrogenase Activity Assay Kit                                Sigma                                           Cat\# MAK066                                 

  Commercial assay, kit                                    Phosphoglucose Isomerase Colorimetric Assay Kit                         Sigma                                           Cat\# MAK103                                 

  Genetic reagent (*Drosophila*\                           *HmlG4G80: w\*; HmlΔ-Gal4\*; P{tubPGal80ts}\**                          Cross made in our laboratory by Tomas Dolezal                                                
  *melanogaster*)                                                                                                                                                                                                               

  Genetic reagent (*D. melanogaster)*                      *Hml \> GFP: w; HmlΔ-Gal4 UAS-eGFP*                                     Provided by Bruno Lemaitre                                                                   

  Genetic reagent\                                         *Hif1α\[RNAi\]: P{KK110834}VIE-260B*                                    Vienna Drosophila Resource Center               VDRC: v106504                                FBst0478328
  (*D. melanogaster)*                                                                                                                                                                                                           

  Genetic reagent (*D. melanogaster*)                      *TRiP control: y(1) v(1)*; *P{y\[+t7.7\]=CaryP}attP2*                   Bloomington\                                    BDSC: 36303                                  FBst0036303
                                                                                                                                   Drosophila Stock Center                                                                      

  Genetic reagent (*D. melanogaster)*                      *KK control: y, w\[1118\]*;*P{attP,y\[+\],w\[3\`\]}*                    Bloomington Drosophila Stock Center             BDSC: 60100                                  FBst0060100

  Genetic reagent (*D. melanogaster)*\                     *Ldh\[RNAi\]: y(1) v(1); P{y\[+t7.7\] v\[+t1.8\]=TRiP.HMS00039}attP2*   Bloomington\                                    BDSC: 33640                                  FBst0033640
                                                                                                                                   Drosophila Stock Center                                                                      

  Genetic reagent (*D. melanogaster)*                      *HRE-LacZ: HRE-HRE-CRE-LacZ*                                            Provided by Pablo Wappner ([@bib36])                                                         

  Genetic reagent (*D. melanogaster)*                      *Ldh-mCherry*                                                           Provided by Jason Tennessen                                                                  

  Genetic reagent (*D. melanogaster)*                      *w: w^1118^*                                                            Genetic background based on CantonS                                                          

  Sequence-based reagent                                   Cis forward: 5′TTCGATTGACTCCAGCCTGG3′                                   KRD                                             CG14740                                      FBgn0037988

  Sequence-\                                               Cis reverse: 5′AGCCGGGAACCACCTGTCC3′                                    KRD                                             CG14740                                      FBgn0037988
  based reagent                                                                                                                                                                                                                 

  Sequence-based reagent                                   Ldh forward:\                                                           KRD                                             CG10160                                      FBgn0001258
                                                           5′CAGAGAAGTGGAACGAGCTG3′                                                                                                                                             

  Sequence-\                                               Ldh reverse:\                                                           KRD                                             CG10160                                      FBgn0001258
  based reagent                                            5′CATGTTCGCCCAAAACGGAG3′                                                                                                                                             

  Sequence-based reagent                                   Eno forward: 5′CAACATCCAGTCCAACAAGG3′                                   KRD                                             CG17654                                      FBgn0000579

  Sequence-based reagent                                   Eno reverse: 5′GTTCTTGAAGTCCAGATCGT3′                                   KRD                                             CG17654                                      FBgn0000579

  Sequence-based reagent                                   Gapdh1 forward:\                                                        KRD                                             CG12055                                      FBgn0001091
                                                           5′TTG TGG ATC TTA CCG TCC GC3′                                                                                                                                       

  Sequence-based reagent                                   Gapdh1 reverse: 5′CTCGAACACAGACGAATGGG3′                                KRD                                             CG12055                                      FBgn0001091

  Sequence-based reagent                                   HexA forward: 5′ATATCGGGCATGTATATGGG3′                                  KRD                                             CG3001                                       FBgn0001186

  Sequence-based reagent                                   HexA reverse:\                                                          KRD                                             CG3001                                       FBgn0001186
                                                           5′CAATTTCGCTCACATACTTGG3′                                                                                                                                            

  Sequence-based reagent                                   Pfk forward:\                                                           KRD                                             CG4001                                       FBgn0003071
                                                           5′AGCTCACATTTCCAAACATCG3′                                                                                                                                            

  Sequence-based reagent                                   Pfk reverse: 5′TTTGATCACCAGAATCACTGC3′                                  KRD                                             CG4001                                       FBgn0003071

  Sequence-based reagent                                   Pgi forward: 5′ACTGTCAATCTGTCTGTCCA3′                                   KRD                                             CG8251                                       FBgn0003074

  Sequence-based reagent                                   Pgi reverse: 5′GATAACAGGAGCATTCTTCTCG3′                                 KRD                                             CG8251                                       FBgn0003074

  Sequence-based reagent                                   Rp49 forward: 5′AAGCTGTCGCACAAATGGCG3′                                  KRD                                             CG7939                                       FBgn0002626

  Sequence-based reagent                                   Rp49 reverse: 5′GCACGTTGTGCACCAGGAAC3′                                  KRD                                             CG7939                                       FBgn0002626

  Sequence-based reagent                                   Hif1α forward: 5′CCAAAGGAGAAAAGAAGGAAC3′                                KRD                                             CG45051                                      FBgn0266411

  Sequence-based reagent                                   Hif1α reverse: 5′GAATCTTGAGGAAAGCGATG3′                                 KRD                                             CG45051                                      FBgn0266411

  Sequence-based reagent                                   CG10219 forward: 5′GAGATCTCCGTGAGTGCGC3′                                KRD                                             CG10219                                      FBgn0039112

  Sequence-based reagent                                   CG10219 reverse: 5′CTCCACGCCCCAATGGG3′                                  KRD                                             CG10219                                      FBgn0039112

  Sequence-based reagent                                   Scsα1 forward: 5′TCACAAGCGCGGCAAGATC3′                                  KRD                                             CG1065                                       FBgn0004888

  Sequence-based reagent                                   Scsα1 reverse: 5′TTGATGCCCGAATTGTACTCG3′                                KRD                                             CG1065                                       FBgn0004888

  Sequence-based reagent                                   Tpi forward: 5′AGATCAAGGACTGGAAGAACG3′                                  KRD                                             CG2171                                       FBgn0086355

  Sequence-based reagent                                   Tpi reverse: 5′ACCTCCTTGGAGATGTTGTC3′                                   KRD                                             CG2171                                       FBgn0086355

  Software, algorithm                                      Graphpad Prism                                                          <https://www.graphpad.com/>                     Graphpad Prism                               RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)

  Software, algorithm                                      Microsoft Excel                                                         <https://www.microsoft.com/>                    Microsoft Excel                              

  Software, algorithm                                      Fiji                                                                    ImageJ - <https://fiji.sc>                      ImageJ                                       RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)

  Other                                                    S3e Cell Sorter                                                         BioRad -<http://www.bio-rad.com/>               BioRad                                       

  Other                                                    Olympus FluoView 1000                                                   Olympus -<https://www.olympus-global.com/>      [Olympus](https://www.olympus-global.com/)   RRID:[SCR_017015](https://scicrunch.org/resolver/SCR_017015)\
                                                                                                                                                                                                                                RRID:[SCR_014215](https://scicrunch.org/resolver/SCR_014215)

  Other                                                    Olympus SZX12                                                           Olympus -<https://www.olympus-global.com/>      [Olympus](https://www.olympus-global.com/)   

  Other                                                    Olympus IX71                                                            Olympus -\                                      [Olympus](https://www.olympus-global.com/)   
                                                                                                                                   <https://www.olympus-global.com/>                                                            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Drosophila melanogaster* strains {#s4-1}
---------------------------------

Flies were raised on a diet containing cornmeal (80 g/l), agar (10 g/l), yeast (40 g/l), saccharose (50 g/l) and 10% methylparaben (16.7 mL/l) and were kept in a controlled humidity environment with natural 12 hr/12 hr light/dark periods at 25°C, except for those used in temperature-controlled Gal80 experiments. Flies bearing Gal80 were transferred at 29°C 24 hr prior to infection in order to degrade temperature-sensitive Gal 80 protein. Prior to experiments, flies were kept in plastic vials on 0% glucose diet (cornmeal 53.5 g/l, agar 6.2 g/l, yeast 28.2 g/l and 10% methylparaben 16.7 mL/l) for 7 days and transferred into fresh vials every second day without CO~2~ in order to ensure good condition of the food. Infected flies were kept on 0% glucose diet in incubators at 29°C due to the temperature sensitivity of *S. pneumoniae*. Drosophila Stock Centre in Bloomington provided TRiP control and Ldh\[RNAi\] flies. Hif1α\[RNAi\] and KK control flies were obtained from Vienna Drosophila Resource Center. Ldh-mCherry strain was kindly provided by Jason Tennessen, HRE-LacZ by Pablo Wappner and Hml \> GFP by Bruno Lemaitre. The w1118 strain has a genetic background based on CantonS.

Bacterial strain and fly injection {#s4-2}
----------------------------------

The *S. pneumoniae* strain EJ1 was stored at −80°C in Tryptic Soy Broth (TSB) media containing 16% glycerol. For the experiments, bacteria were streaked onto agar plates containing 3% TSB and 100 μg/mL streptomycin and subsequently incubated at 37°C + 5% CO~2~ overnight. Single colonies were inoculated into 3 mL of TSB liquid media with 100 μg/mL of streptomycin and 100,000 units of catalase and incubated at 37°C + 5% CO~2~ overnight. Bacterial density was measured after an additional 4 hr so that it reached an approximate 0.4 OD600. Final bacterial cultures were centrifuged and dissolved in phosphate-buffered saline (PBS) so the final OD reached A = 2.4. The *S. pneumoniae* culture was kept on ice prior to injection and during the injection itself. Seven-day-old males (survival experiments, qPCR assays, measurement of metabolites and enzymatic activity) or females (X-gal staining, NBDG assay) were anaesthetized with CO~2~ and injected with 50 nL culture containing 20,000 *S. pneumoniae* bacteria or 50 nL of mock buffer (PBS) into the ventrolateral side of the abdomen using an Eppendorf Femtojet Microinjector.

Pathogen load measurement {#s4-3}
-------------------------

Sixteen randomly chosen flies per genotype and treatment were anaesthetized with CO~2~ and individually homogenized in 200 µL PBS using a motorized plastic pestle. Serial dilutions were plated onto TSB agar plates and incubated at 37°C overnight. The number of colonies was counted at 0, 24, 48 and 72 hpi. Collected data were compared using Tukey\'s multiple comparisons test in Graphpad Prism software. Sidak\'s multiple comparison correction was performed.

Survival analysis {#s4-4}
-----------------

Injected flies were kept at 29°C in vials with approximately 30 individuals per vial and were transferred onto a fresh food every other day. Dead flies were counted daily. At least three independent experiments were performed and combined into one survival curve created in Graphpad Prism software; the individual experiments showed comparable results. Average number of individuals was more than 500 for each genotype. Data were analyzed by Log-rank and Grehan-Breslow-Wilcoxon tests (which gave more weight to deaths at early time points).

Isolation of hemocytes {#s4-5}
----------------------

GFP-labeled hemocytes were isolated from HmlΔ-Gal4 UAS-eGFP male flies using fluorescence-activated cell sorting (FACS). Approximately 200 flies were anaesthetized with CO~2~, washed in PBS and homogenized in 600 μL of PBS using a pestle. Homogenate was sieved through a nylon cell strainer (⌀ 40 μm). This strainer was then additionally washed with 200 µL of PBS, which was added to the homogenate subsequently. Samples were centrifuged (3 min, 6°C, 3500 RPM) and the supernatant was washed in ice cold PBS after each centrifugation (3x). Prior to sorting, samples were transferred to polystyrene FACS tubes using a disposable bacterial filter (⌀ 50 µm, Sysmex) and sorted into 100 µL of TRIzol Reagent (Invitrogen) using a S3TM Cell Sorter (BioRad). Sorted cells were verified by fluorescent microscopy and by differential interference contrast (DIC).

Gene expression {#s4-6}
---------------

Sorted hemocytes were homogenized using a DEPC-treated pestle and RNA was extracted by TRIzol Reagent (Invitrogen) according to the manufacturer\'s protocol. Superscript III Reverse Transcriptase (Invitrogen) and oligo(dT)20 primer was used for reverse transcription. Amounts of mRNA of particular genes were quantified on a CFX 1000 Touch Real-Time Cycler (Bio-Rad) using the TP 2x SYBR Master Mix (Top-Bio) in three technical replicates with the following conditions: initial denaturation for 3 min at 95°C, then amplification for 15 s at 94°C, 30 s at 54°C, 40 s at 72°C for 40 cycles and melting curve analysis at 65--85°C/step 0.5°C. Primer sequences are listed in the Key Resources Table. qPCR data were analyzed with double delta Ct analysis, and expressions or particular genes were normalized to the expression of Ribosomal protein 49 (Rp49) in the same sample. Relative values (fold change) to control were compared and are shown in the graphs. Samples for gene expression analysis were collected from three independent experiments. Data were compared with Tukey\'s multiple comparisons test in Graphpad Prism software. Sidak\'s multiple comparison correction was performed.

Glucose uptake {#s4-7}
--------------

HmlΔ-Gal4 UAS-eGFP adults were placed on a cornmeal diet with an added 200 µL of 2-NBDG (excitation/emission maxima of \~465/540 nm, 5 mg/mL stock (used 10,000x diluted), Thermo-Fisher), which was soaked into the surface of food, immediately after infection (flies analyzed at 24 hpi) or 96 hpi (flies analyzed at 120 hpi). After 1 day, flies were prepared for microscopy (Olympus IX71). Flies for glucose uptake analysis were collected from three independent experiments.

Activation of the hypoxia response element (HRE) {#s4-8}
------------------------------------------------

X-gal staining was performed on infected HRE-HRE-CRE-LacZ females. Flies were dipped in 75% EtOH for 1 s in order to make their cuticle non-hydrophobic and dissected in PBS. Fixation was performed with 2.5% glutaraldehyde/PBS on a LabRoller rotator for 7 min at room temperature. Adults were then washed three times in PBS. Next, two washings were performed with a PT solution (1 mL 10xPBS (Ambion), 100 µL 1M MgCl~2~ × 6H~2~O, 300 µL 10% Triton, 8 mL dH~2~O, 320 µL 0.1M K~4~\[Fe(CN)~6~\], 320 µL 0.1 M K~3~\[Fe(CN)~6~\]) for 10 min. Finally, PT solution with few grains of X-gal (Sigma) was added. Samples were placed in a thermoblock at 37°C and occasionally mixed, and the colorimetric reaction was monitored. The reaction was stopped with three PBS washings at the same time for all samples. Samples for HRE activation evaluation were collected from four independent experiments.

Concentration of metabolites {#s4-9}
----------------------------

Five flies were homogenized in 200 µL of PBS and centrifuged (3 min, 4°C, 8000 RPM) for glycogen measurement. For lactate and glucose measurement, hemolymph was isolated from 25 adult males by centrifugation (14,000 RPM, 5 min) through a silicagel filter into 50 µL PBS. Half of all samples were used for the quantification of proteins. Samples for glucose, glycogen and lactate measurement were denatured at 75°C for 10 min, whereas samples for protein quantification were stored in −80°C. Glucose was measured using a Glucose (GO) Assay (GAGO-20) Kit (Sigma) according to the manufacturer's protocol. Colorimetric reaction was measured at 540 nm. For glycogen quantification, sample was mixed with amyloglucosidase (Sigma) and incubated at 37°C for 30 min. A Bicinchoninic Acid Assay (BCA) Kit (Sigma) was used for protein quantification according to the supplier\'s protocol and the absorbance was measured at 595 nm. A Lactate Assay Kit (Sigma) was used for lactate concentration quantification according to the manufacturer\'s protocol. The absorbance was measured at 570 nm. Samples for metabolite concentration were collected from six independent experiments. Measured data were compared in Graphpad Prism using Tukey\'s multiple comparisons test. Sidak\'s multiple comparison correction was performed.

Enzymatic activity {#s4-10}
------------------

The enzymatic activities of lactate dehydrogenase and phosphoglucose isomerase were measured using a Lacate Dehydrogenase Activity Assay Kit (Sigma) or a Phosphoglucose Isomerase Colorimetric Assay Kit (Sigma), respectively, according to the supplier\'s protocol in 10,000 FACS-sorted hemocytes for each sample. Colorimetric reaction was measured at 450 nm. Samples for enzymatic activity detection were collected from six independent experiments. Measured values were compared in Graphpad Prism software using Tukey\'s multiple comparisons test. Sidak\'s multiple comparison correction was performed.

Genotypes of experimental models {#s4-11}
--------------------------------

### [Figure 1](#fig1){ref-type="fig"} {#s4-11-1}

1.  \(B\) Hml \>GFP refers to HmlΔ-Gal4 UAS-eGFP/HmlΔ-Gal4 UAS-eGFP; +/+

### [Figure 2](#fig2){ref-type="fig"} {#s4-11-2}

1.  (A--B, D--G) Hml \>GFP refers to HmlΔ-Gal4 UAS-eGFP/HmlΔ-Gal4 UAS-eGFP; +/+

### [Figure 3](#fig3){ref-type="fig"} {#s4-11-3}

1.  \(A\) HRE-LacZ refers to HRE-HRE-CRE-LacZ/HRE HRE-CRE-LacZ; +/+

2.  \(B\) Hml \>GFP Ldh-mCherry corresponds to HmlΔ-Gal4 UAS-eGFP, Ldh-mCherry/HmlΔ-Gal4 UAS-eGFP, Ldh-mCherry; +/+

3.  (C--E) Hml \>GFP refers to HmlΔ-Gal4 UAS-eGFP/HmlΔ-Gal4 UAS-eGFP; +/+

4.  \(E\) Hml \>GFP Hif1α\[RNAi\] corresponds to HmlΔ-Gal4 UAS-eGFP/UAS-Hif1α\[RNAi\]; +/+

### [Figure 4](#fig4){ref-type="fig"} {#s4-11-4}

1.  (A, D--F) Hml x KK control corresponds to HmlΔ-Gal4 UAS-eGFP/KK control; +/+; and Hml \>Hif1α\[RNAi\] refers to HmlΔ-Gal4 UAS-eGFP/UAS-Hif1α\[RNAi\]; +/+

2.  \(B\) Hml \>GFP refers to HmlΔ-Gal4 UAS-eGFP/HmlΔ-Gal4 UAS-eGFP; +/+; and Hml \>Hif1α\[RNAi\] refers to HmlΔ-Gal4 UAS-eGFP/UAS- Hif1α\[RNAi\]; +/+

3.  (C, G--I) Hml x TRiP control corresponds to HmlΔ-Gal4 UAS-eGFP/+; TRiP control/+; and Hml \>Ldh\[RNAi\] refers to HmlΔ-Gal4 UAS-eGFP/+; UAS-Ldh\[RNAi\]/ +

### [Figure 5](#fig5){ref-type="fig"} {#s4-11-5}

1.  (A, B, C) Hml x TRiP control corresponds to HmlΔ-Gal4 UAS-eGFP/+; TRiP control/+; and Hml \>Ldh\[RNAi\] corresponds to HmlΔ-Gal4 UAS-eGFP/+; UAS-Ldh\[RNAi\]/ +; and Hml \>Hif1α\[RNAi\] refers to HmlΔ-Gal4 UAS-eGFP/UAS-Hif1α\[RNAi\]; +/+; and Hml x KK control corresponds to HmlΔ-Gal4 UAS-eGFP/KK control; +/+

### [Figure 6](#fig6){ref-type="fig"} {#s4-11-6}

1.  (A, C) Hml \>Hif1α\[RNAi\] refers to HmlΔ-Gal4/+; P{tubPGal80ts}/UAS-Hif1α\[RNAi\]; and Hml x KK control corresponds to HmlΔ-Gal4/KK control; P{tubPGal80ts}/+

2.  (B, D) w x Ldh\[RNAi\] refers to +/+; UAS-Ldh \[RNAi\]/+; and Hml \>Ldh\[RNAi\] corresponds to HmlΔ-Gal4/+; P{tubPGal80ts}/UAS-Ldh\[RNAi\]
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Thank you for submitting your article \"*Drosophila* macrophages switch to aerobic glycolysis to mount effective antibacterial defense\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, including Utpal Banerjee as the Reviewing and Senior Editor, and Reviewer \#1. The following individual involved in review of your submission has agreed to reveal their identity: Ulrich Theopold (Reviewer \#2).

The reviewers have discussed the reviews with one another and drafted this decision to help you prepare a revised submission.

As you can see from the reviews, most of the comments on the general assessment of the paper can be addressed by simply rewriting some parts of the Discussion section. I have also included some experiments that I believe would strengthen the study. However following discussions with Uli Theopold, we decided that these should not be made mandatory for publication. I still include them here for your potential benefit but we believe your work is important and do not wish to hold up publication. So we leave it up to you to decide whether or not to include some of these experiments. Please do, however, attend to the suggested changes to the Discussion.

Summary:

The paper titled \"*Drosophila* macrophages switch to aerobic glycolysis to mount effective antibacterial defense\" by Krejčová et al. addresses the role of metabolic reprograming and activation of aerobic glycolysis in macrophages following septic infection. The authors induce sepsis in adult flies by injection of *Streptococcus* into the hemocoel and then isolate marked macrophages by FACS at different stages of the infections and monitor the changes in metabolic and transcriptional profiles during the acute and resolution stages of the macrophages and compare it with control. The principal conclusion of this study is that as in mammals, *Drosophila* macrophages also undergo metabolic reprograming and increase aerobic glycolysis, which is essential for mounting a strong defense against the infection. This process is mediated by the Hypoxia induced factor expression in normoxic conditions resulting in increased transcriptional expression of glycolytic enzymes and LDH. Additionally, the authors also describe a systemic response mediated by macrophage activation which changes the glucose metabolism based on the increase in the levels of circulating glucose and a concomitant depletion of glycogen reserves.

Essential revisions:

The experiments performed are straightforward, and, for the most part, support the conclusions reached by the authors. Both of the major conclusions -- that glycolysis is activated during macrophage immune reaction, and the proposal that Hif is involved in this process -- are supported by the data.

1\) There is less data to describe any mitochondrial metabolic changes that occur during infection and the lack of changes in TCA cycle gene expression do not support one mechanism or other. Either attempt some of the suggested experiments, or discuss this matter as a future goal and limitation of the current study.

2\) The manuscript shows that aerobic glycolysis (AG) as a means of adjusting immune reactions is conserved among invertebrates with both local and systemic effects. This might come as no surprise to *Drosophila* researchers, but evolutionary connections, particularly when it pertains to immunity is not widely appreciated and needs to be explicitly discussed.

3\) There is an increasing interest in understanding how metabolism shapes immunity in mammals and establishing this in *Drosophila* is a major step forward making the phenomenon amenable to genetics. When relating the findings in this manuscript to immunology in general we would suggest you go even further and cite/discuss some recent concepts on the relevance of immune metabolism for trained immunity (for example: Netea and coworkers in Seminars in Immunol. 2016). Trained immunity has not been studied much in insects but may relate to the mechanistically poorly characterized immune priming in invertebrates.

4\) What is the nature of the systemic signal? If unknown to the authors, it is still valuable to discuss its possible origins and identity.

5\) Although not central to the study, mitochondrial dynamics is influenced when cells undergo metabolic reprograming to aerobic glycolysis. One of the target genes Hif-1α is PDK1, which phosphorylates PDH and renders it inactive thus blocking the TCA cycle. Increased phospho-PDH can correlate with mitochondrial fragmentation and increased ROS production. Given the interconnections between different pathways it would be important to monitor the status of the mitochondria in normal and activated macrophages in acute and resolution stages. Minimally, discuss these ideas in the manuscript.

6\) In the Discussion section, the manuscript would benefit from a more in depth discussion of the evolutionary implications of immune adjustments via AG. Due to their pleiotropic character the coding regions may be under too much constraint preventing changes but genome scans for fast-evolving regions may have identified markers in regulatory regions. Is there any evidence for positive selection/sweeps for the genes in question (the authors rightly mention many are induced upon immune activation). Data may be available for both mammals and insects/invertebrates.

10.7554/eLife.50414.021

Author response

> Essential revisions:
>
> The experiments performed are straightforward, and, for the most part, support the conclusions reached by the authors. Both of the major conclusions -- that glycolysis is activated during macrophage immune reaction, and the proposal that Hif is involved in this process -- are supported by the data.
>
> 1\) There is less data to describe any mitochondrial metabolic changes that occur during infection and the lack of changes in TCA cycle gene expression do not support one mechanism or other. Either attempt some of the suggested experiments, or discuss this matter as a future goal and limitation of the current study.

We agree that our paper would benefit from in depth analysis of mitochondrial dynamics. Therefore, we discuss the analysis of mitochondrial metabolism as a goal of our future study (Discussion, fifth paragraph).

> 2\) The manuscript shows that aerobic glycolysis (AG) as a means of adjusting immune reactions is conserved among invertebrates with both local and systemic effects. This might come as no surprise to *Drosophila* researchers, but evolutionary connections, particularly when it pertains to immunity is not widely appreciated and needs to be explicitly discussed.

We are aware of the evolutionary importance of our findings and hence we discuss it (Discussion, third paragraph).

> 3\) There is an increasing interest in understanding how metabolism shapes immunity in mammals and establishing this in *Drosophila* is a major step forward making the phenomenon amenable to genetics. When relating the findings in this manuscript to immunology in general we would suggest you go even further and cite/discuss some recent concepts on the relevance of immune metabolism for trained immunity (for example: Netea and coworkers in Seminars in Immunol. 2016). Trained immunity has not been studied much in insects but may relate to the mechanistically poorly characterized immune priming in invertebrates.

The relevance of our data for concept of trained immunity is discussed in Discussion, seventh paragraph.

> 4\) What is the nature of the systemic signal? If unknown to the authors, it is still valuable to discuss its possible origins and identity.

In our previous work, we identified extra-cellular adenosine as an effector molecule responsible for similar effect. Nevertheless, we expect pleiotropy of several candidate molecules that we believe may serve as a systemic signal. Moreover, our current research is focused on role of gene ImpL2 in the induction of systemic metabolic changes in the context of infection (manuscript in prep.) --see Discussion, sixth paragraph.

> 5\) Although not central to the study, mitochondrial dynamics is influenced when cells undergo metabolic reprograming to aerobic glycolysis. One of the target genes Hif-1α is PDK1, which phosphorylates PDH and renders it inactive thus blocking the TCA cycle. Increased phospho-PDH can correlate with mitochondrial fragmentation and increased ROS production. Given the interconnections between different pathways it would be important to monitor the status of the mitochondria in normal and activated macrophages in acute and resolution stages. Minimally, discuss these ideas in the manuscript.

We appreciate your ideas for our future work concerning mitochondrial metabolism. The importance of mitochondrial metabolism for the described process is obvious. We mention these ideas in the Discussion (fifth paragraph).

> 6\) In the Discussion section, the manuscript would benefit from a more in depth discussion of the evolutionary implications of immune adjustments via AG. Due to their pleiotropic character the coding regions may be under too much constraint preventing changes but genome scans for fast-evolving regions may have identified markers in regulatory regions. Is there any evidence for positive selection/sweeps for the genes in question (the authors rightly mention many are induced upon immune activation). Data may be available for both mammals and insects/invertebrates.

Even though we tried to get deeper into the principles of population and evolutionary genetics, we are not experts in the field and we are afraid that we can interpret the data in a misleading way.

Therefore we decided just discuss aspects of evolutional conservation of hypoxia control of metabolic switch between AG and mitochondrial metabolism (Discussion, third paragraph).

[^1]: Regional Centre for Biotechnology, Faridabad, India.
